cenobamate

In quick start to new year's M&A, Arvelle Therapeutics hands reins to Angelini as it nears EU approval for cenobamate
Endpoints
Mon, 01/4/21 - 10:41 am
Arvelle Therapeutics
Angelini Pharma
M&A
CNS
epilepsy
cenobamate
Axovant